Key facts
- This page summarizes John R. Treace's Form 4 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 11 May 2022, 17:59.
John R. Treace - 09 May 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)
- Reporting relationship
- Director
- Issuer ticker
- TMCI
- Reported as of
- 09 May 2022
- Net transaction value
- -$1,050,676
- SEC form
- 4
- Accepted by SEC
- 11 May 2022, 17:59:33 UTC
- Prior SEC filing
- 11 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lisa Taylor as Attorney-in-fact for John R. Treace
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John R. Treace filed Form 4 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 11 May 2022.
Change
- Previous filing in this sequence was filed on 11 Feb 2022.
- Current net transaction value: -$1,050,676.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMCI
transaction
Common Stock
Sale
- Transaction value
- $496,190
- Shares
- -37,312
- Change %
- -2%
- Price
- $13.30
- Shares after
- 1,860,478
- Date
- 09 May 2022
- Ownership
- John R. Treace and Ginger D. Treace JTTEN
- Footnotes
- F1, F2
TMCI
transaction
Common Stock
Sale
- Transaction value
- $269,387
- Shares
- -18,966
- Change %
- -1%
- Price
- $14.20
- Shares after
- 1,841,512
- Date
- 09 May 2022
- Ownership
- John R. Treace and Ginger D. Treace JTTEN
- Footnotes
- F1, F3
TMCI
transaction
Common Stock
Sale
- Transaction value
- $280,197
- Shares
- -18,415
- Change %
- -1%
- Price
- $15.22
- Shares after
- 1,823,097
- Date
- 09 May 2022
- Ownership
- John R. Treace and Ginger D. Treace JTTEN
- Footnotes
- F1, F4
TMCI
transaction
Common Stock
Sale
- Transaction value
- $4,902
- Shares
- -307
- Change %
- -0.02%
- Price
- $15.97
- Shares after
- 1,822,790
- Date
- 09 May 2022
- Ownership
- John R. Treace and Ginger D. Treace JTTEN
- Footnotes
- F1, F5
TMCI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 408,816
- Date
- 09 May 2022
- Ownership
- As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.93 to $13.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.93 to $14.86 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.93 to $15.891 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.96 to $15.97 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F6
The Reporting Person disclaims beneficial ownership of shares held in trusts for which his spouse is a co-trustee.